[Ketamine hydrochloride by continuous infusion in modern anesthesiology].

C. Altissimi,E. Frezzolini,G. Leggio,Paolo Torroni

1980-08-01

Minerva Anestesiologica

Abstract:

What problem does this paper attempt to address?

Understanding Barriers to HPV Vaccination: Perspectives From Air Force Family Medicine Physicians and Active Duty Air Force Males

Courtney E Halista,Randolph J Kline,Jennifer Bepko

DOI: https://doi.org/10.1093/milmed/usz403

2020-06-08

Abstract:Introduction: Genital human papillomavirus (HPV) is the most common sexually transmitted infection in the United States. The Center for Disease Control Advisory Committee on Immunization Practices (ACIP) has recognized the potential benefits of immunizing young men beginning at age 11 or 12 years and continuing through age 21 years. The maximum age of immunization is extended through age 26 for men who have sex with men, transgender individuals, and immunocompromised men. In spite of these recommendations, vaccination of young men is currently limited by numerous patient and provider variables. The authors sought to delineate these variables as they pertain to members of the U.S. Air Force in order to guide future interventions. Methods: The study consisted of two cross-sectional surveys at a single Air Force Base in California. The protocol was approved by the Institutional Review Board at David Grant Medical Center. The physician survey consisted of 10 questions that were formatted and designed to assess physicians' knowledge about the quadrivalent HPV vaccine (Gardasil) and 6 questions that were formatted and designed to assess physicians' counseling practices regarding Gardasil. The physician survey was distributed electronically via email in January 2017 to all 48 Family Medicine physicians, including both residents and staff, within the Family Medicine Residency Clinic at Travis Air Force Base. The email contained a link via Microsoft Share-point to an anonymous online survey. The patient survey was distributed in paper form to all male service members between the ages of 18 and 30 years who attended Commander's Calls over a 90-day period between January 2017 and March 2017. The patient survey included the primary outcome: proportion of respondents who had completed the HPV vaccination series. Descriptive statistics, including frequencies and percentages, were used to summarize the data. Contingency tables were constructed and the chi-square test or Fisher's Exact Test were performed to determine if particular demographic variables were associated with correct answers to individual knowledge questions. Results: The majority of the Family Medicine physicians surveyed have adequate knowledge of HPV and the vaccine but do not routinely offer the vaccine to their male patients. Inadequate time during the office visit was cited as the major limitation to vaccine promotion. Of the Active Duty Air Force males surveyed, only 27% completed the vaccine series. A lack of knowledge regarding the personal benefits of the vaccine and failure to remember to receive subsequent doses were cited as barriers to completion. Only one-quarter of all surveyed males were interested in speaking with a healthcare provider about HPV and/or the HPV vaccine. Conclusion: Deficiencies in public knowledge and insufficient provider practices are likely contributing to the suboptimal rates of HPV vaccination among eligible males. Additionally, eligible males are not interested in speaking with their healthcare providers about either HPV or the HPV vaccine. If the rates of HPV vaccination within the male population are to increase, health educators, public health proponents, and vaccine advocates need to devise a more effective approach to disseminate this information to eligible male recipients.
Serum markers in community-acquired pneumonia and ventilator-associated pneumonia

P. Póvoa

DOI: https://doi.org/10.1097/QCO.0b013e3282f47c32

2008-04-01

Current Opinion in Infectious Diseases

Abstract:Purpose of reviewThis article reviews recent data on the usefulness of serum markers in community-acquired pneumonia and ventilator-associated pneumonia. The focus is on clinical studies, with an emphasis on adult critically ill patients. Recent findingsSerum markers have demonstrated potential value in early prediction and diagnosis of pneumonia, in monitoring the clinical course and in guiding antibiotic therapy. C-reactive protein appears to perform better in diagnosing infection, because several studies have shown that procalcitonin may remain undetectable in some patients, specifically those with pneumonia. Procalcitonin exhibited a better correlation with clinical severity, however. Furthermore, one report demonstrated the efficacy and safety of procalcitonin-guided antibiotic therapy in community-acquired pneumonia. SummarySerum markers should only be used as a complementary tool to support the current clinical approach. Use of serum markers, in particular procalcitonin and C-reactive protein, represents a promising strategy in the clinical decision-making process in patients in whom pneumonia is suspected. Specifically, these markers can be used to guide culture sampling and empirical antibiotic prescription, and to monitor the clinical course, adjust the duration of antibiotic therapy and identify nonresponders, in whom an aggressive diagnostic and therapeutic approach may prevent further clinical deterioration.
Human Papillomavirus (HPV) Risk Factors, Vaccination Patterns, and Vaccine Perceptions Among a Sample of Male College Students

Holly B. Fontenot,Heidi Collins Fantasia,Anna Charyk,Melissa A. Sutherland

DOI: https://doi.org/10.1080/07448481.2013.872649

2014-03-05

Journal of American College Health

Abstract:OBJECTIVE: To examine human papillomavirus (HPV) vaccination rates, including initiation and completion of the vaccine series, and barriers to vaccination in a sample of male college students.PARTICIPANTS: Male students between the ages of 18 and 25 who reported being currently or previously sexually active (N = 735).METHODS: A cross-sectional Web-based survey was administered during October 2012 at a large public university in the northeast United States. Student e-mail addresses were obtained from the university after institutional review board approval.RESULTS: Although condom use was low and number of lifetime sexual partners was high, 93% reported they were not at risk for sexually transmitted infections. The college men in the sample had low HPV vaccine awareness, knowledge, perceived severity, and perceived susceptibility, and 74% of the sample had not obtained the HPV vaccine.CONCLUSIONS: There is a disconnect between actual and perceived risks of HPV and barriers to HPV vaccination exist.

public, environmental & occupational health,education & educational research
Decreased aorto‐septal angle may contribute to left ventricular diastolic dysfunction in healthy subjects

K. Okada,T. Mikami,S. Kaga,M. Nakabachi,Ayumu Abe,S. Yokoyama,H. Nishino,M. Nishida,Chikara Shimizu,H. Iwano,S. Yamada,H. Tsutsui

DOI: https://doi.org/10.1002/jcu.22126

2014-07-08

Journal of Clinical Ultrasound

Abstract:Left ventricular (LV) diastolic dysfunction is often observed in healthy older subjects without structural heart disease, although its exact mechanisms have not been established. A decrease in the aorto‐septal angle (ASA), an alteration of LV shape due to aortic elongation, is also frequently seen in elderly subjects. The objective of this study was to evaluate whether it can contribute to LV diastolic dysfunction in healthy subjects.
Evidence of a new, preferentially Mg-carrying, transport system besides the fast Na and the slow Ca channels in the excited myocardial sarcolemma membrane.

F. Späh,A. Fleckenstein

DOI: https://doi.org/10.1016/0022-2828(79)90397-3

IF: 5.763

1979-10-01

Journal of Molecular and Cellular Cardiology

Abstract:
HPV vaccine behaviors and intentions among a diverse sample of women aged 27-45 years: implications for shared clinical decision-making

Jennifer D Allen,Nadia N Abuelezam,Raviv Rose,Katelin Isakoff,Gregory Zimet,Holly B Fontenot

DOI: https://doi.org/10.1186/s12889-024-18740-2

IF: 4.5

2024-08-08

BMC Public Health

Abstract:Background: The Advisory Committee on Immunization Practices issued a shared clinical decision-making (SCDM) recommendation for HPV vaccination in persons aged 27-45. Since expanded eligibility for the vaccine was issued, little information has been available about HPV vaccine behaviors and intentions among women in this age group. Methods: We conducted a cross-sectional online survey among women aged 27-45 years recruited through a Qualtrics™ respondent panel (N = 324) to answer the following questions (1) What is the prevalence of HPV vaccination among a diverse sample of adult women aged 27-45 years? (2) What are the characteristics of those who have or have not previously been vaccinated? and (3) What factors are associated with the intention to obtain the HPV vaccine among those who had never been vaccinated? Multivariable logistic regression analyses estimated adjusted odds ratios (AORs) and 95% confidence intervals (95% CIs). Results: Only 31.1% had at least one dose of the HPV vaccine. In multivariable analyses, those more likely to have been vaccinated were younger and were more likely to believe that the vaccine was effective. Of those unvaccinated or unsure, 54.8% indicated they were likely to get vaccinated in the future. Factors associated with future vaccine intention (compared to those not intending) included beliefs about vaccine testing, perceived likelihood of HPV infection, greater comfort in asking one's provider for vaccination, and prior negative healthcare experiences. Conclusions: Our findings suggest that many women in this age group are interested in HPV vaccination. While the recommendation is for SCDM rather than routine vaccination for all women in this age group, efforts to promote informed decision-making among mid-adult women may include educating women about the rigorous vaccine testing and approval process, their risk factors for HPV infection, and encouraging them to engage in SCDM with their medical providers. Targeted efforts to reach women who have had negative experiences with healthcare may also be needed.
Optimal Scheduling for Real-Time Parallel Tasks

W. Lee,Heejo Lee

DOI: https://doi.org/10.1093/ietisy/e89-d.6.1962

2006-06-01

Abstract:We propose an optimal algorithm for the real-time scheduling of parallel tasks on multiprocessors, where the tasks have the properties of flexible preemption, linear speedup, bounded parallelism, and arbitrary deadline. The proposed algorithm is optimal in the sense that it always finds out a feasible schedule if one exists. Furthermore, the algorithm delivers the best schedule consuming the fewest processors among feasible schedules. In this letter, we prove the optimality of the proposed algorithm. Also, we show that the time complexity of the algorithm is O(M2 · N2) in the worst case, where M and N are the number of tasks and the number of processors, respectively.
Human Papilloma Virus Vaccination Knowledge, Prevalence, Risk Factors, and HPV Detection in 18-26 and 27-45-year-old Men and Women

Pavel V Chernyshov,Tetiana Semushyna,Liudmyla Verbytska,Pavlo V Fedorych,Anna Avramenko,Tetiana Osaulenko,Yulia V Zolotonosha

Abstract:The US Food and Drug Administration approved a supplemental application for HPV 9-valent vaccine for 27-45-year-old women and men. The Advisory Committee on Immunization Practices did not recommend catch-up vaccination of adults aged 27-45 years, but recognized that some adults who were not previously vaccinated may be at risk for new HPV infection and might benefit from vaccination in this age range. We decided to compare HPV vaccination knowledge, prevalence, risk factors, and history of HPV detection in cohorts with ages of 18-26 and 27-45 years. Men and women aged 18-45 years were asked to complete an anonymous internet survey about HPV infection and vaccination. Valid answers were received from 524 respondents. HPV vaccination rates were low (from 0.00 to 5.56%). All women aged 27-45 years bought the vaccine at their own cost and were vaccinated after sexual debut. Knowledge on existence of the HPV vaccine was better in women (P<0.01). The overall number of sexual partners was significantly higher in men and in persons aged 27-45 (P<0.05). Women aged 27-45 reported higher prevalence of unprotected vaginal and anal sex, a higher number of sexual partners, and lower HPV-related cancer awareness. Our study showed that better knowledge on HPV vaccination and HPV-related cancer awareness did not lead to higher HPV vaccination rates. A substantial number of individuals aged 27-45 years may benefit from HPV vaccination, and information on HPV vaccination should be actively disseminated by physicians and mass media.
How Very Young Men Who Have Sex with Men View Vaccination Against Human Papillomavirus.

Huachun Zou,Andrew E. Grulich,Alyssa M. Cornall,Sepehr N. Tabrizi,Suzanne M. Garland,Garrett Prestage,Catriona S. Bradshaw,Jane S. Hocking,Andrea Morrow,Christopher K. Fairley,Marcus Y. Chen

DOI: https://doi.org/10.1016/j.vaccine.2014.05.043

IF: 4.169

2014-01-01

Vaccine

Abstract:Background: HPV vaccination of men who have sex with men (MSM) prior to the commencement of sexual activity would have the maximum impact on preventing HPV and anal cancer in this population. However, knowledge and attitudes towards HPV vaccination among very young MSM have not been previously studied.Methods: Two hundred MSM aged 16 to 20 were recruited via community and other sources. Participants were asked about their knowledge and attitudes towards HPV and HPV vaccination.Results: Most (80%, 95% confidence interval (CI) 72.2-87.2%) men were not willing to purchase the vaccine because of its cost (AUD$450). However, if the vaccine was offered to MSM free of charge, 86% (95% Cl: 80-90%) reported they would be willing to disclose their sexuality to a health care provider in order to obtain the vaccine. Over half (54%, 95%: 47-61%) of men would only be willing to disclose their sexuality to receive the HPV vaccine after their first experience of anal intercourse. The age at first insertive anal intercourse and the age at first receptive anal intercourse were 0.21 (IQR: -2.5 to 3.2) and 0.17 (IQR: -2.9 to 2.7) years earlier than the age that men would be willing to disclose their sexuality to receive the HPV vaccine, respectively. Willingness to receive the vaccine at a younger age was associated with younger age at first insertive anal intercourse.Conclusion: Overall, very young MSM expressed high acceptance of HPV vaccination. Early, opportunistic vaccination of very young MSM may be feasible in settings where very young MSM have not been vaccinated through universal programs targeting school aged males. However, given HPV infections occur early on, the effectiveness of this approach will be less than vaccination targeting school aged boys. (C) 2014 Elsevier Ltd. All rights reserved.
Characterization and horizontal transfer of class 1 integrons in Salmonella strains isolated from food products of animal origin.

H. Meng,Zhigang Zhang,Miaorui Chen,Yongyu Su,Lin Li,S. Miyoshi,He Yan,Lei Shi

DOI: https://doi.org/10.1016/j.ijfoodmicro.2011.07.006

2011-10-03

Abstract:
The Role of Health Beliefs in HPV Vaccine Uptake Among Young Men During the Dutch Catch-Up Campaign in 2023

Femke Hilverda,Linda Siebers,Manja Vollmann

DOI: https://doi.org/10.1027/2512-8442/a000156

2024-10-30

European Journal of Health Psychology

Abstract:Background: Human papillomavirus (HPV) infection is associated with the development of various cancers. An effective way to prevent HPV-related cancer is vaccination. In 2023, the Dutch government started a vaccination catch-up campaign in which, particularly, young men between the ages of 19 and 26 were invited to receive the HPV vaccine free of charge. Aims: This study aimed to estimate the relevance of the determinants proposed by the Health Belief Model (HBM) regarding HPV vaccine uptake among young men. Method: A cross-sectional survey was completed by 155 Dutch young men aged 19–26 years. The HBM determinants of perceived susceptibility, perceived severity, perceived benefits, and perceived barriers were measured along with HPV vaccine uptake as an outcome. The relevance of the HBM determinants for HPV vaccine uptake was determined by confidence interval-based estimation of relevance (CIBER). Results: In total, 54 participants got vaccinated since the start of the campaign. Perceived benefits and barriers were strongly related to vaccine uptake, while most young men perceived many benefits and few barriers. Perceived severity showed a moderate association with vaccine uptake, while most young men perceived the consequences of HPV infections as moderately severe. Perceived susceptibility was not significantly related to vaccine uptake. Limitations: The sample mainly consisted of higher-educated participants and no information about ethnicity was obtained. Only determinants of the HBM were included. Cross-sectional data and self-reports on vaccination status were used. Conclusion: Public health interventions should focus on increasing the perceived severity, while simultaneously reinforcing beliefs about many benefits and few barriers.

psychology, clinical
Factors Associated with HPV Vaccination Among Middle-Aged Adults in the United States

Tyler J Gallagher,Jason Chwa,Matthew E Lin,Niels C Kokot

DOI: https://doi.org/10.1002/ohn.952

2024-08-27

Abstract:Objective: To examine prevalence of partial and complete HPV vaccination among middle-aged adults and factors associated with vaccination status. Study design: Nationally representative cross-sectional survey. Setting: United States. Methods: Cohort includes adults aged 30 to 44 years from 2018 to 2022 Behavioral Risk Factor Surveillance System (BRFSS) survey who completed questions about HPV vaccination status. Survey-weighted multivariable logistic regression was utilized to explore factors associated with partial and complete HPV vaccination status. Results: In this nationally representative cohort of 26,470 US middle-aged adults, 15.8% [95% confidence interval [CI]: 15.1%-16.6%] reported any HPV vaccination, and 6.5% [95% CI: 6.0%-7.0%] reported complete HPV vaccination. On multivariable regression, younger age, female sex, residence in the West or Northeast, higher educational attainment, unmarried status, having a personal healthcare provider, and gay or lesbian sexual orientation were associated with increased likelihood of vaccination. Race was variably associated with vaccination status. Annual income, insurance status, cancer history, head and neck cancer history, and time of last physician checkup were not associated with HPV vaccination status. Conclusion: HPV vaccination among middle-aged adults who were not previously vaccinated should be based on risk for new HPV infection and possible benefits of vaccination. While our analysis shows that consideration of personal factors likely plays a role in HPV vaccination in this cohort, we also find that gaps in vaccination may exist due to other socioeconomic disparities between sexes, educational attainment levels, racial/ethnic groups, geographic regions, and access to a personal healthcare provider. These factors' influence suggests potential room for improved public health measures.
Psychosocial determinants of parental human papillomavirus (HPV) vaccine decision-making for sons: Methodological challenges and initial results of a pan-Canadian longitudinal study

Samara Perez,Ovidiu Tatar,Gilla K Shapiro,Eve Dubé,Gina Ogilvie,Juliet Guichon,Vladimir Gilca,Zeev Rosberger

DOI: https://doi.org/10.1186/s12889-016-3828-9

IF: 4.5

2016-12-05

BMC Public Health

Abstract:Background: HPV vaccination decision-making is a complex process that is influenced by multiple psychosocial determinants. Given the change in policy recommendation to include males in routine HPV vaccination, our goals were to assess the HPV vaccination uptake in Canada, to understand where Canadian parents were situated in the HPV vaccine decision-making process for their son, how they changed over time and which psychosocial determinants were relevant for this process. Methods: We used an online survey methodology and collected data from a nationally representative sample of Canadian parents of boys aged 9-16 at baseline (T1, February 2014) and at 9 months' follow-up (T2). Our analyses were guided by the Precaution Adoption Process Model (PAPM), a theoretical health behavior model that classifies parents in one of six stages: unaware, unengaged, undecided, decided not to vaccinate, decided to vaccinate and those who had already vaccinated their sons. Rigorous methods were used to filter out careless responders: response variance, bogus items, psychometric antonyms and psychometric synonyms. Results: At T1 and T2, we received 3,784 and 1,608 respectively completed questionnaires; after data cleaning 3,117 (T1) and 1,427 (T2) were retained. Less than 3% of boys were vaccinated at both time points. At both T1 and T2, most parents (over 70%) belonged to the earlier vaccination adoption stages: 57% were unaware (T1) and 15.3% (T2); 20.9% were unengaged (T1) and 32.4% (T2); and 9.1% were undecided (T1) and 25.2% (T2). At follow-up, 37.7% of participants did not move from their initial PAPM decision-making stage. Most parents (55%) preferred to receive information from their healthcare provider (HCP) but only 6% (T1) and 12% (T2) had actually spoken with a HCP about the HPV vaccine for their son. Conclusions: HPV vaccination uptake in Canadian boys was very low in the absence of a publicly funded HPV vaccination programs for boys. Optimal HPV information preferences were identified and can be used in interventions to increase HPV knowledge and increase HPV vaccine uptake. Intentions to vaccinate or planning to speak to one's HCP did not translate into action for most parents over the 9-month follow up; this finding is critical to consider to inform implementation strategies. Methodological challenges are described and suggestions for future research are offered.
Predictors of Adults’ Knowledge and Awareness of HPV, HPV-Associated Cancers, and the HPV Vaccine: Implications for Health Education

Kimberly R. McBride,Shipra Singh

DOI: https://doi.org/10.1177/1090198117709318

2017-06-09

Abstract:High human papillomavirus (HPV) prevalence and low HPV vaccine uptake are significant public health concerns. Disparities in HPV-associated cancers and HPV vaccine uptake rates suggest the need for additional research examining factors associated with vaccine acceptance. This study assessed HPV awareness and knowledge and identified sociodemographic characteristics associated with HPV knowledge at the population level. Data from adult men ( n = 1,197) and women ( n = 1,906) who participated in the National Cancer Institute's 2014 Health Information National Trends Survey were analyzed. Multivariable regression was used to identify predictors of four HPV knowledge categories: (1) general knowledge, (2) cervical cancer knowledge, (3) "other" cancer knowledge (i.e., anal, oral, penile), and (4) vaccine knowledge. Significant gender differences in awareness and knowledge of HPV and the HPV vaccine were revealed. Most participants (>70%) knew that HPV could cause cervical cancer, but fewer (14.9% to 31.5%) knew of the association between HPV and "other" cancers. Women were more likely to report that a health care provider recommended vaccination. Significant predictors of general HPV and HPV vaccine knowledge included gender, education, income, race, and other sociodemographic characteristics. Age and income predicted cervical cancer knowledge. Knowledge of "other" HPV-associated cancers was predicted by having a child under 18 years in the household and relationship status. HPV knowledge appears to be socially patterned. Low HPV knowledge among men and some racial minorities suggests a need for further intervention. Health education should emphasize risks of noncervical HPV-associated cancers. Patient-provider communication that includes education, counseling, and clear recommendations favoring vaccination may improve uptake.

public, environmental & occupational health
Human Papillomavirus (HPV) Vaccination Intent among Mothers of Adolescent Sons: A National Survey on HPV Knowledge, Attitudes and Beliefs in South Korea

Jihye Choi,Seyoung Kim,Seung-Ju Lee,Sangrak Bae,Sooyoun Kim

DOI: https://doi.org/10.5534/wjmh.210262

Abstract:Purpose: Human papillomavirus (HPV) is one of the most common sexually transmitted infections affecting both males and females but there is an apparent lack of knowledge and apprehension towards male HPV vaccination South Korea. The purpose of the present study was to examine the associations between knowledge and perceptions of male HPV vaccination and vaccination intent among Korean mothers of adolescent sons. Materials and methods: We conducted a cross-sectional study using a nationwide online survey. The independent variables were mothers' sociodemographic characteristics, history of HPV diagnosis, general HPV knowledge, HPV vaccine knowledge, and attitudes and beliefs towards male HPV vaccination. The outcome variable was mothers' intent to vaccinate their sons, which was classified into three categories: non-intent, undecided and intend to vaccinate. We performed univariate analysis and multinomial logistic regression analysis. Results: A total of 906 eligible mothers completed the survey. Mothers received low scores on the HPV-related knowledge scales with low ratings on the scale measuring perceived risk of HPV. Approximately 10% of the mothers intended to vaccinate their sons against HPV, 61.0% were undecided and 1.5% already had their sons vaccinated. According to the multinominal logistic regression analysis, having a daughter in the family, mothers' previous diagnosis with HPV, general HPV knowledge, influence, harm, and risk were significantly associated with being undecided and having intentions to vaccinate their sons (p<0.05). Conclusions: Our study revealed that Korean mothers are generally less aware of male HPV vaccination, have low perceived risk of HPV, and remain highly hesitant on vaccinating their sons against HPV. It is therefore important to raise public awareness about male HPV vaccination and alleviate vaccine hesitancy. Such efforts will contribute to improving parents' vaccination intent, increasing vaccine uptake among male adolescents and prevention of HPV-associated diseases.
Examining HPV vaccination behavior among young adults: Insights from applying the Health Belief Model

Oluwafemifola Oyedeji,Kristina W. Kintziger,Cary M. Springer,Samantha Ehrlich,Jill Maples,Justin Gatwood,Cristina S. Barroso

DOI: https://doi.org/10.1371/journal.pone.0312700

IF: 3.7

2024-11-02

PLoS ONE

Abstract:Despite evidence-based recommendations for HPV vaccination, uptake among young adults is suboptimal. Limited research has explored factors that may influence HPV vaccination among young adults, as well as associated promotion and informational preferences in this group. This study aimed to examine factors associated with HPV vaccination among young adults and preferences for HPV vaccine information and promotion. This study utilized a cross-sectional design to examine factors related to HPV vaccination among young adults on a university campus in Tennessee. Data were collected via an online survey administered to students, aged 18–26 years, from March–May 2023. Study measures included sociodemographic characteristics, health/healthcare-related factors, and perception-related measures. Data analysis included descriptive statistics and multivariable logistic regression analysis. Out of 402 participants that completed the survey, 209 reported being vaccinated against HPV. In the adjusted model, variables associated with HPV vaccination were perceived risk (adjusted OR [aOR] = 1.12; 95% confidence interval [CI]:1.05, 1.20), perceived barriers (aOR = 0.73; 95% CI: 0.66, 0.81), higher HPV knowledge (aOR = 1.17; 95% CI: 1.03, 1.33), and receipt of healthcare provider recommendations (aOR = 12.90; 95% CI: 7.08, 23.51). Study findings suggest that those who are vaccinated were more likely to report receiving healthcare provider recommendations, low perceived barriers, higher HPV knowledge and perceived risk. Future HPV vaccination promotion efforts for young adults may consider increasing HPV vaccine knowledge and awareness, addressing barriers, and strengthening provider recommendations.

multidisciplinary sciences
Perceptions of HPV-Linked Oropharyngeal Cancer Risk Messages Among a Sample of Young Adult Men in the US: A Pilot Study

Alyssa H. Harrell,George C. Kueppers,Robin C. Vanderpool,David Dean,Jacob A. Rohde

DOI: https://doi.org/10.1177/15579883241252524

2024-05-21

American Journal of Men s Health

Abstract:American Journal of Men's Health, Volume 18, Issue 3, May-June 2024. Awareness of risk for oropharyngeal cancer from oral human papillomavirus (HPV) infection is low among men in the United States. This pilot study tested messages communicating oral HPV and oropharyngeal cancer risk among a sample of U.S. young adult men (aged 18–26). Six oral HPV and cancer risk messages were tested in an online survey. Participants (N = 68) were randomly assigned to one of two message sets, each containing three unique text-based messages. Participants evaluated messages separately based on various measures (e.g., perceived message effectiveness [PME], novelty). One-way repeated measures ANOVAs were used to assess evaluation differences within message sets. Participants provided open-ended feedback about each message, which were synthesized into overarching themes. Participants were receptive to the risk messages, rating them high on PME (mean range = 3.72–4.25 out of 5) and other measures. Analyses identified three high-performing messages. For example, participants rated a message about HPV-linked oropharyngeal cancer risk rates in men versus women higher on attention and novelty than two other messages in the same set (both ps < .05). Participants were shown three messages (instead of all six) in each message set to minimize survey fatigue. Common themes from open-ended feedback were that participants liked the short-form structure of the messages and that the messages used gender-tailored language. In conclusion, oral HPV and oropharyngeal cancer risk messages may be useful for increasing risk awareness among men in the U.S. Further work should test such messages in rigorous experimental contexts to assess their efficacy in modifying other health outcomes, such as HPV vaccination behaviors.

public, environmental & occupational health
Acceptance of human papillomavirus vaccine among boys in Asia: A narrative review

Xiaoya Fu,Xiang Guo,Jia Lu,Weiyu Zhou,Yihan Lu

DOI: https://doi.org/10.1080/21645515.2024.2429894

2024-12-01

Human Vaccines & Immunotherapeutics

Abstract:Human papillomavirus (HPV) is a prevalent sexually transmitted infection globally, linked to genital warts and various cancers. The burden of HPV-related diseases in males is rising significantly. We reviewed studies published until September 2024 from databases like PubMed, Embase®, and Web of Science, summarizing HPV vaccination acceptance among boys and parents in Asia and exploring influencing factors. Acceptance rates for HPV vaccination among boys ranged from 48.4% to 69.9%, while parental acceptance varied from 10.0% to 91.0%. Recent years have shown a positive trend in acceptance, influenced by perceived risk and benefits, barriers, sociodemographic characteristics, knowledge and awareness of HPV and its vaccine, and social support factors. Targeted educational interventions are crucial for increasing awareness of male-associated HPV diseases and for dispelling misconceptions. The future implementation of gender-neutral vaccination policies may facilitate broader acceptance. Future studies should focus on developing interventions to promote pan-gender HPV vaccination.

immunology,biotechnology & applied microbiology
Anogenital Human Papillomavirus (HPV) Infection, Seroprevalence, and Risk Factors for HPV Seropositivity Among Sexually Active Men Enrolled in a Global HPV Vaccine Trial

Joseph E Tota,Anna R Giuliano,Stephen E Goldstone,Brady Dubin,Alfred Saah,Alain Luxembourg,Christine Velicer,Joel M Palefsky

DOI: https://doi.org/10.1093/cid/ciab603

2022-04-09

Abstract:Background: In men, the incidence of human papillomavirus (HPV)-related cancer is rising, but data regarding male HPV infection and seroprevalence are available from only a few countries. Methods: This analysis of a global HPV vaccine trial evaluated baseline data from 1399 human immunodeficiency virus-negative heterosexual men (HM) and men who have sex with men (MSM). Key objectives included assessment of HPV prevalence and risk factors for seropositivity to 9-valent HPV (9vHPV) vaccine types (6, 11, 16, 18, 31, 33, 45, 52, and 58), and concordance between seropositivity and prevalent HPV type. Results: Overall, 455 of 3463 HM (13.1%) and 228 of 602 MSM (37.9%) were HPV DNA positive for any 9vHPV vaccine type at baseline. Infection prevalence and seroprevalence (≥1 9vHPV vaccine type) were 13.2% and 8.1%, respectively, among 333 HM from Europe, and 37.9% and 29.9%, respectively, among 335 MSM from Europe or North America. Among men with baseline infection, MSM had higher seroprevalence for concordant HPV types (39.5% vs 10.8% in HM). The seropositivity risk (irrespective of baseline infection status) was higher among MSM versus HM (age-adjusted odds ratio, 3.0 [95% confidence interval, 2.4-6.4]). Among MSM, statistically significant seropositivity risk factors included younger age at sexual debut, higher number of receptive anal sex partners, and less frequent condom use. No factors assessed were associated with seropositivity in HM. Conclusions: Higher proportions of MSM than HM were HPV DNA positive and seropositive, and concordance between HPV DNA positivity and seropositivity, a potential marker of true infection versus carriage, was higher in MSM. Most MSM and HM were seronegative for all 9vHPV vaccine types, suggesting the potential benefit of catch-up vaccination after sexual debut.Clinical Trials Registration. NCT00090285.
[Analysis on Willingness to Receive Human Papillomavirus Vaccination among Risk Males and Related Factors].

Xiaojun Meng,Tianjian Jia,Xuan Zhang,Chen Zhu,Xin Chen,Huachun Zou

2015-01-01

Abstract:OBJECTIVE:To understand the willingness to receive human papillomavirus (HPV) vaccination of men who have sex with men (MSM) and the male clients of sexually transmitted disease (STD) clinics and related factors in China.METHODS:MSM were enrolled from the community through snowball sampling and male clients of STD clinics were enrolled from a sexual health clinic through convenience sampling in Wuxi, China. A questionnaire survey on the subjects' socio-demographic characteristics and the awareness of HPV was conducted.RESULTS:A total of 186 MSM and 182 STD clients were recruited. The awareness rates of HPV were 18.4% and 23.1%, respectively and the awareness rates of HPV vaccination were 10.2% and 15.4%, respectively. STD clinic clients (70.9%) were more likely to receive HPV vaccination than MSM (34.9%) (χ² = 47.651, P<0.01). Only 26.2% of MSM and 20.2% of STD clinic clients were willing to receive free HPV vaccination before the age of 20 years. Multivariate logistic regression analysis showed that MSM who had passive anal sex (OR=2.831, 95% CI: 1.703-13.526) , MSM who never used condom in anal sex in the past 6 months (OR=3.435, 95% CI: 1.416-20.108) , MSM who had been diagnosed with STDs (OR=1.968, 95% CI: 1.201-8.312) and STD clinic clients who had commercial sex with females in the past 3 months (OR=1.748, 95% CI: 1.207-8.539) , STD clinic clients who never used condom in commercial sex in the past 3 months (OR=1.926, 95% CI: 1.343-5.819) and STD clinic clients who had been diagnosed with STDs in past 12 months (OR=2.017, 95% CI: 1.671-7.264) were more likely to receive free HPV vaccination.CONCLUSION:Sexually active MSM and male clients in STD clinics in China had lower awareness of the HPV related knowledge. Their willing to receive HPV vaccination were influenced by their behavior related factors. It is necessary to strengthen the health education about HPV and improve people's awareness of HPV vaccination.

[Ketamine hydrochloride by continuous infusion in modern anesthesiology].

Understanding Barriers to HPV Vaccination: Perspectives From Air Force Family Medicine Physicians and Active Duty Air Force Males

Serum markers in community-acquired pneumonia and ventilator-associated pneumonia

Human Papillomavirus (HPV) Risk Factors, Vaccination Patterns, and Vaccine Perceptions Among a Sample of Male College Students

Decreased aorto‐septal angle may contribute to left ventricular diastolic dysfunction in healthy subjects

Evidence of a new, preferentially Mg-carrying, transport system besides the fast Na and the slow Ca channels in the excited myocardial sarcolemma membrane.

HPV vaccine behaviors and intentions among a diverse sample of women aged 27-45 years: implications for shared clinical decision-making

Optimal Scheduling for Real-Time Parallel Tasks

Human Papilloma Virus Vaccination Knowledge, Prevalence, Risk Factors, and HPV Detection in 18-26 and 27-45-year-old Men and Women

How Very Young Men Who Have Sex with Men View Vaccination Against Human Papillomavirus.

Characterization and horizontal transfer of class 1 integrons in Salmonella strains isolated from food products of animal origin.

The Role of Health Beliefs in HPV Vaccine Uptake Among Young Men During the Dutch Catch-Up Campaign in 2023

Factors Associated with HPV Vaccination Among Middle-Aged Adults in the United States

Psychosocial determinants of parental human papillomavirus (HPV) vaccine decision-making for sons: Methodological challenges and initial results of a pan-Canadian longitudinal study

Predictors of Adults’ Knowledge and Awareness of HPV, HPV-Associated Cancers, and the HPV Vaccine: Implications for Health Education

Human Papillomavirus (HPV) Vaccination Intent among Mothers of Adolescent Sons: A National Survey on HPV Knowledge, Attitudes and Beliefs in South Korea

Examining HPV vaccination behavior among young adults: Insights from applying the Health Belief Model

Perceptions of HPV-Linked Oropharyngeal Cancer Risk Messages Among a Sample of Young Adult Men in the US: A Pilot Study

Acceptance of human papillomavirus vaccine among boys in Asia: A narrative review

Anogenital Human Papillomavirus (HPV) Infection, Seroprevalence, and Risk Factors for HPV Seropositivity Among Sexually Active Men Enrolled in a Global HPV Vaccine Trial

[Analysis on Willingness to Receive Human Papillomavirus Vaccination among Risk Males and Related Factors].